<i>N</i>-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK
作者:Agnese C. Pippione、Stefano Sainas、Antonella Federico、Elisa Lupino、Marco Piccinini、Michael Kubbutat、Jean-Marie Contreras、Christophe Morice、Alessandro Barge、Alex Ducime、Donatella Boschi、Salam Al-Karadaghi、Marco L. Lolli
DOI:10.1039/c8md00068a
日期:——
Resulting from hit-to-lead optimization, the aminopyrazole3ais a NIK inhibitor selective over 44 kinases.
由于击中导向优化,氨基吡唑3a是一种选择性超过44种激酶的NIK抑制剂。
SMALL MOLECULE CFTR CORRECTORS
申请人:Discoverybiomed Inc.
公开号:EP2922852A1
公开(公告)日:2015-09-30
US9676779B2
申请人:——
公开号:US9676779B2
公开(公告)日:2017-06-13
[EN] SMALL MOLECULE CFTR CORRECTORS<br/>[FR] CORRECTEURS DE CFTR À PETITES MOLÉCULES
申请人:DISCOVERYBIOMED INC
公开号:WO2014081820A1
公开(公告)日:2014-05-30
Novel CFTR corrector compounds that are effective in rescuing halide efflux, delF508-CFTR protein processing, and apical functional chloride ion transport in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cystic fibrosis). The methods include administering a CFTR corrector compound or pharmaceutically acceptable salt or prodrug thereof. Methods of rescuing halide efflux in a cell, correcting a processing defect of a delF508-CFTR protein in a cell, and correcting functional delF508-CFTR chloride channels in a cell are also provided.